Phase I trial of weekly topotecan and gemcitabine in patients with solid tumors.
about
A phase I study of topotecan and gemcitabine in advanced solid tumors.Chemotherapy-induced weakness and fatigue in skeletal muscle: the role of oxidative stress.A novel oral camptothecin analog, gimatecan, exhibits superior antitumor efficacy than irinotecan toward esophageal squamous cell carcinoma in vitro and in vivo.
P2860
Phase I trial of weekly topotecan and gemcitabine in patients with solid tumors.
description
2009 nî lūn-bûn
@nan
2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Phase I trial of weekly topotecan and gemcitabine in patients with solid tumors.
@ast
Phase I trial of weekly topotecan and gemcitabine in patients with solid tumors.
@en
type
label
Phase I trial of weekly topotecan and gemcitabine in patients with solid tumors.
@ast
Phase I trial of weekly topotecan and gemcitabine in patients with solid tumors.
@en
prefLabel
Phase I trial of weekly topotecan and gemcitabine in patients with solid tumors.
@ast
Phase I trial of weekly topotecan and gemcitabine in patients with solid tumors.
@en
P2093
P2860
P1476
Phase I trial of weekly topotecan and gemcitabine in patients with solid tumors.
@en
P2093
Dong M Shin
Edward S Kim
Fadlo R Khuri
J Jack Lee
Joseph L Lee
Scott M Lippman
Waun K Hong
William N William
P2860
P356
10.1097/COC.0B013E318178E513
P577
2009-02-01T00:00:00Z